McKesson Corporation
MCK
Kedudukan dalam Saham
#187
McKesson Corporation is a prominent global provider of healthcare services,... McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally, the company's dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas.
Harga Saham
$1,029.14
Disegerakkan terakhir: 2026-10-20
Modal Pasaran
$119.99B
Perubahan (1 hari)
1.73%
Perubahan (1 tahun)
30.72%
Negara
US
Perdagangan McKesson Corporation (MCK)
Kategori
Healthcare
Hasil untuk McKesson Corporation (MCK)
Hasil pada Jun 2026 TTM: $410.98B
Menurut laporan kewangan terkini daripada McKesson Corporation, hasil semasa syarikat (TTM) ialah $410.98B. Pada tahun 2024, syarikat memperoleh hasil sebanyak $308.95B peningkatan berbanding hasil pada tahun 2023 iaitu $276.71B. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi McKesson Corporation dari 2000 hingga 2026
Hasil pada akhir setiap tahun
| Tahun | Hasil | Ubah |
|---|---|---|
| 2026 (TTM) | $410.98B | 14.46% |
| 2025 | $359.05B | 16.22% |
| 2024 | $308.95B | 11.65% |
| 2023 | $276.71B | 4.83% |
| 2022 | $263.97B | 10.80% |
| 2021 | $238.23B | 3.11% |
| 2020 | $231.05B | 7.81% |
| 2019 | $214.32B | 2.86% |
| 2018 | $208.36B | 4.95% |
| 2017 | $198.53B | 4.01% |
| 2016 | $190.88B | 6.61% |
| 2015 | $179.05B | 30.11% |
| 2014 | $137.61B | 12.38% |
| 2013 | $122.46B | -0.23% |
| 2012 | $122.73B | 9.50% |
| 2011 | $112.08B | 3.11% |
| 2010 | $108.70B | 1.94% |
| 2009 | $106.63B | 4.85% |
| 2008 | $101.70B | 9.39% |
| 2007 | $92.98B | 5.60% |
| 2006 | $88.05B | 9.36% |
| 2005 | $80.51B | 15.84% |
| 2004 | $69.51B | 21.68% |
| 2003 | $57.12B | 14.23% |
| 2002 | $50.01B | 19.03% |
| 2001 | $42.01B | 14.36% |
| 2000 | $36.73B | 0.00% |
Hasil untuk syarikat atau pesaing serupa
| Syarikat | Hasil | Perbezaan Hasil | Negara |
|---|---|---|---|
| - | - |
US
|
|
| $254.25B | -38.14% |
US
|
|
| - | - |
US
|
|
| $7.64B | -98.14% |
AU
|
|
| $13.60B | -96.69% |
US
|
